AF
RCUS icon

Allworth Financial’s Arcus Biosciences RCUS Stock Holding History

Allworth Financial’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73K Buy
80
+53
+196% +$1.15K ﹤0.01% 4388
2025
Q4 		$644 Buy
27
+23
+575% +$469 ﹤0.01% 4473
2025
Q3 		$55 Buy
+4
New +$42 ﹤0.01% 4738
2023
Q4 		– Sell
-53
Closed -$952 – 3589
2023
Q3 		$952 Hold
53
– – ﹤0.01% 2868
2023
Q2 		$1.08K Hold
53
– – ﹤0.01% 2706
2023
Q1 		$967 Buy
53
+23
+77% +$440 ﹤0.01% 2682
2022
Q4 		$620 Hold
30
– – ﹤0.01% 2578
2022
Q3 		$1K Buy
+30
New +$793 ﹤0.01% 2474

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Allworth Financial's RCUS Position: Q1 2026 in Review

Allworth Financial increased its Arcus Biosciences (RCUS) stake by 196% in Q1 2026, buying an estimated $1.15K and bringing the position to 80 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #4388.

Allworth Financial first reported a position in RCUS in Q3 2022 and has held it in 8 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Allworth Financial held 80 shares of Arcus Biosciences worth $1.73K as of Q1 2026.
  • Allworth Financial bought 53 Arcus Biosciences shares in Q1 2026, an estimated $1.15K.
  • Arcus Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4388 holding.
  • Allworth Financial first reported a position in Arcus Biosciences in Q3 2022 and has held it in 8 quarters since.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.